Who buys ANAVEX life sciences stock?
AVXL stock was acquired by a variety of institutional investors in the last quarter, including Investors Financial Group LLC. View insider buying and selling activity for Anavex Life Sciences or or view top insider-buying stocks.
What are analysts'price targets for ANAVEX life sciences'stock?
6 equities research analysts have issued 1-year price objectives for Anavex Life Sciences' stock. Their forecasts range from $20.00 to $40.00. On average, they expect Anavex Life Sciences' stock price to reach $33.83 in the next year.
How do I contact ANAVEX?
The biotechnology company can be reached via phone at (844) 689-3939 or via email at [email protected]. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Does avxl stock pay a dividend?
Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price. AVXL is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased.
Is anavex a good stock to buy?
Anavex Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Will Avxl go up?
Anavex Life Sciences Corp (NASDAQ:AVXL) The 5 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 39.00, with a high estimate of 42.00 and a low estimate of 16.00. The median estimate represents a +228.01% increase from the last price of 11.89.
Where can I buy Avxl?
How to Buy AvaXlauncher (AVXL) [For Beginners]1.1 Visit Binance's Website (https://www.binance.com/en) Sign Up Binance Now. ... 1.2 Fill in your trading details. ... 1.3 Allow 2FA-Two-factor authentication (Optional)
Why did Avxl stock go up?
Anavex Life Sciences (AVXL) surged Monday on a positive study in Rett Syndrome, helping AVXL stock extend a triple-digit gain over a five-week rally. The biotech company is working on a treatment for Rett Syndrome, a neurological disorder that affects almost exclusively girls.
Will Sava stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Cassava Sciences Inc have a median target of 79.00, with a high estimate of 124.00 and a low estimate of 8.00. The median estimate represents a +234.75% increase from the last price of 23.60.
Should I buy or sell Anavex Life Sciences stock right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anavex Life Sciences in the last twelve months. There are currently 5 buy...
What is Anavex Life Sciences' stock price forecast for 2022?
5 brokers have issued 1-year price targets for Anavex Life Sciences' shares. Their forecasts range from $34.00 to $42.00. On average, they anticipa...
How has Anavex Life Sciences' stock performed in 2022?
Anavex Life Sciences' stock was trading at $17.34 at the beginning of the year. Since then, AVXL stock has decreased by 53.3% and is now trading at...
When is Anavex Life Sciences' next earnings date?
Anavex Life Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast fo...
How were Anavex Life Sciences' earnings last quarter?
Anavex Life Sciences Corp. (NASDAQ:AVXL) announced its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported ($0.14) EP...
Who are Anavex Life Sciences' key executives?
Anavex Life Sciences' management team includes the following people: Dr. Christopher U. Missling M.B.A. , M.S., Ph.D., Chairman, Pres, CEO & Sec....
Who are some of Anavex Life Sciences' key competitors?
Some companies that are related to Anavex Life Sciences include Beam Therapeutics (BEAM) , Bavarian Nordic A/S (BVNRY) , Fate Therapeutics (FATE...
What other stocks do shareholders of Anavex Life Sciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Anavex Life Sciences investors own include Inovio Pharmace...
What is Anavex Life Sciences' stock symbol?
Anavex Life Sciences trades on the NASDAQ under the ticker symbol "AVXL."
About Anavex Life Sciences
Anavex Life Sciences (NASDAQ:AVXL) Frequently Asked Questions
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases.
Transparency is our policy. Learn how it impacts everything we do
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anavex Life Sciences in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Anavex Life Sciences stock. View analyst ratings for Anavex Life Sciences or view top-rated stocks.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
How to calculate restricted stock?
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
Premium Research for AVXL
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
What is Anavex Life Sciences?
ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases.
Does market cap include convertible securities?
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVE
